Impaired Humoral Response to Third Dose of BNT162b2 mRNA COVID-19 Vaccine Despite Detectable Spike Protein-specific T cells in Lung Transplant Recipients

Transplantation. 2022 Mar 1;106(3):e183-e184. doi: 10.1097/TP.0000000000004021.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Lung
  • RNA, Messenger
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus
  • T-Lymphocytes
  • Transplant Recipients*

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • RNA, Messenger
  • Spike Glycoprotein, Coronavirus
  • BNT162 Vaccine